Heart Failure & Cardiac Rehabilitation Protocol
Heart Failure & Cardiac Rehabilitation Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A comprehensive adjunctive protocol for heart failure patients and cardiac rehabilitation participants, targeting myocardial energetics, cardiac fibrosis, vascular function, and the autonomic dysregulation that perpetuates heart failure progression.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Heart Failure & Cardiac Rehabilitation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing; reassess cardiac function (echo, BNP) at 3-month intervals; always adjunct to cardiology care
Target Audience
Heart failure patients (HFrEF/HFpEF) in stable phase; post-MI cardiac rehabilitation participants
| Compound | Dose | Frequency |
|---|---|---|
| Thymosin Beta-4 Cardiac progenitor cell activation, neovascularization, and anti-fibrotic effects post-infarction | 2.5 mg | Twice weekly |
| BPC-157 Autonomic regulation, GI-cardiac axis support, and cardiac vascular protection | 250 mcg | Twice daily |
| SS-31 (Elamipretide) Cardiac mitochondrial cardiolipin protection; restores ATP production in energy-depleted myocardium | 4 mg/kg | Daily |
| NAD+ SIRT3 activation reduces cardiac hypertrophy; critical for NAD+-depleted failing heart | 500 mg (NMN equivalent) | Daily |
| VIP Potent vasodilation and cardiac anti-inflammatory; reduces sympathetic nervous system hyperactivation | 25 nmol | Daily |
| Selank Reduces anxiety-driven sympathetic hyperactivation; supports vagal tone restoration in CHF | 250 mcg | Daily |
Free Peptide Guide
Heart Failure & Cardiac Rehabilitation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Thymosin Beta-4 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Heart Failure & Cardiac Rehabilitation Protocol run before reassessment?
A common window is Ongoing; reassess cardiac function (echo, BNP) at 3-month intervals; always adjunct to cardiology care, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Thymosin Beta-4 + BPC-157 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Heart failure is characterized by mitochondrial dysfunction in cardiomyocytes, adverse cardiac remodeling (fibrosis, hypertrophy), endothelial dysfunction, and autonomic imbalance. Thymosin Beta-4 has the most extensive cardiac evidence base, promoting cardiomyocyte survival, neovascularization, and cardiac progenitor cell activation following ischemic injury. BPC-157 stabilizes the autonomic nervous system and gut-heart axis, reduces cardiac inflammation, and promotes angiogenesis. SS-31 specifically targets cardiolipin in cardiac mitochondria, the most energy-demanding tissue in the body, restoring oxidative phosphorylation efficiency. NAD+ activates SIRT3 to reduce cardiac hypertrophy and oxidative stress. VIP is a potent vasodilator and cardiac anti-inflammatory peptide. Selank reduces the sympathetic hyperactivation characteristic of heart failure.
Clinical Research
No clinical references were provided for this stack yet.
More Cardiovascular Health Stacks
Cardiac Health & Heart Peptide Protocol
Comprehensive cardiac protection stack combining GH secretagogue-mediated cardioprotection, peptide cytoprotection, mitochondrial preservation, and tissue-protective receptor activation.
Cardiovascular Health & Atherosclerosis Prevention Protocol
Cardioprotective peptide protocol targeting endothelial function, plaque stabilization, myocardial protection, and reduction of cardiovascular inflammation in at-risk adults.
Peripheral Artery Disease (PAD) & Vascular Repair Protocol
A protocol for patients with peripheral artery disease targeting therapeutic angiogenesis, collateral vessel development, ischemic muscle protection, and peripheral vasodilation to improve walking distance and limb perfusion.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Heart Failure & Cardiac Rehabilitation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.